Advertisement
Advertisement
U.S. Markets closed
S&P Futures
3,920.50 -2.25 (-0.06%) Dow Futures
31,439.00 -1.00 (-0.00%) Nasdaq Futures
11,907.25 -28.25 (-0.24%) Russell 2000 Futures
1,775.30 +2.50 (+0.14%) Crude Oil
110.19 +0.60 (+0.55%) Gold
1,814.20 -1.70 (-0.09%)
Cannassure Therapeutics Ltd (CSURE.TA)
Tel Aviv - Tel Aviv Delayed Price. Currency in ILA
Add to watchlist
At close: 03:03PM IDT
Advertisement
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 34.00 |
| Open | 34.00 |
| Bid | 33.00 x 0 |
| Ask | 34.00 x 0 |
| Day's Range | 32.10 - 34.00 |
| 52 Week Range | 0.63 - 114.00 |
| Volume | |
| Avg. Volume | 25,073 |
| Market Cap | 17.397M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority
Cannassure Therapeutics Ltd (TASE: CSURE) ("Cannassure"), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
